172 related articles for article (PubMed ID: 34870399)
1. Examining developments in multicancer early detection: highlights of new clinical data from recent conferences.
Beer TM
Am J Manag Care; 2021 Dec; 27(19 Suppl):S347-S355. PubMed ID: 34870399
[TBL] [Abstract][Full Text] [Related]
2. The clinical and economic benefits associated with novel multi-cancer early detection tests: conference highlights from the 2022 ISPOR Annual Meeting.
Nabavizadeh N
Am J Manag Care; 2022 Aug; 28(7 Suppl):S123-S132. PubMed ID: 36067342
[TBL] [Abstract][Full Text] [Related]
3. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
[TBL] [Abstract][Full Text] [Related]
4. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
Lawson HW; Henson R; Bobo JK; Kaeser MK
MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
[TBL] [Abstract][Full Text] [Related]
5. Testing Whether Cancer Screening Saves Lives: Implications for Randomized Clinical Trials of Multicancer Screening.
Welch HG; Dey T
JAMA Intern Med; 2023 Nov; 183(11):1255-1258. PubMed ID: 37639251
[TBL] [Abstract][Full Text] [Related]
6. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
7. Screening for cancer: the economic, medical, and psychosocial issues.
Brill JV
Am J Manag Care; 2020 Nov; 26(14 Suppl):S300-S306. PubMed ID: 33200894
[TBL] [Abstract][Full Text] [Related]
8. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
9. The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm.
Klein EA; Beer TM; Seiden M
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626398
[TBL] [Abstract][Full Text] [Related]
10. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
11. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
[TBL] [Abstract][Full Text] [Related]
12. Dying To Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection Era.
Klein EA; Madhavan S; Beer TM; Bettegowda C; Liu MC; Hartman AR; Hackshaw A
Cancer Epidemiol Biomarkers Prev; 2023 Aug; 32(8):1003-1010. PubMed ID: 37255363
[TBL] [Abstract][Full Text] [Related]
13. Cancer screening rates in individuals with different life expectancies.
Royce TJ; Hendrix LH; Stokes WA; Allen IM; Chen RC
JAMA Intern Med; 2014 Oct; 174(10):1558-65. PubMed ID: 25133746
[TBL] [Abstract][Full Text] [Related]
14. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
[TBL] [Abstract][Full Text] [Related]
15. Novel blood-based early cancer detection: diagnostics in development.
Beer TM
Am J Manag Care; 2020 Nov; 26(14 Suppl):S292-S299. PubMed ID: 33200893
[TBL] [Abstract][Full Text] [Related]
16. Screening for skin cancer.
Helfand M; Mahon SM; Eden KB; Frame PS; Orleans CT
Am J Prev Med; 2001 Apr; 20(3 Suppl):47-58. PubMed ID: 11306232
[TBL] [Abstract][Full Text] [Related]
17. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
18. Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access.
Deverka PA; Douglas MP; Phillips KA
Health Aff (Millwood); 2022 Mar; 41(3):383-389. PubMed ID: 35254936
[TBL] [Abstract][Full Text] [Related]
19. Issues with implementing a high-quality lung cancer screening program.
Mulshine JL; D'Amico TA
CA Cancer J Clin; 2014; 64(5):352-63. PubMed ID: 24976072
[TBL] [Abstract][Full Text] [Related]
20. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut--a secret-shopper survey.
Patel VB; Nahar R; Murray B; Salner AL
Conn Med; 2013 Apr; 77(4):197-203. PubMed ID: 23691732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
